Use of Atalante in hemiplegic and hemiparetic patients
In this document, you will find a compilation of data on the use of Atalante in patients with hemiparesis or hemiplegia as well as the benefits concluded.
Clinical trials sponsored by Wandercraft have provided an indication for the following impairments: complete motor paraplegia, incomplete motor paraplegia, hemiplegia secondary to stroke or any other cause of acute brain injury.
You will read in this study
> Timeline of the clinical studies
> Summary of the clinical studies
> Use in clinical routine data
> Clinical cases
Physiatrist and clinical director at Wandercraft
"Gait training exoskeletons, such as Atalante X, are innovative tools in the management of people with walking impairment. They maximize rehabilitation training; in the hope of improving recovery after a neurological lesion; and in preventing the appearance of complications secondary to prolonged immobilization. Clinical studies comparing Atalante to conventional rehabilitation are undergoing to prove the potential clinical benefits.
In the long term and taking into consideration the current progress in terms of the management of Neurological lesions, particularly with the appearance of new treatments that give hope of repairing or supplementing the nervous system, exoskeletons have their place in maintaining the body in a state of general good health for people in wheelchairs."